var data={"title":"Amniotic fluid embolism syndrome","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Amniotic fluid embolism syndrome</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/contributors\" class=\"contributor contributor_credentials\">Marie R Baldisseri, MD, FCCM</a></dd><dt><span> </span>Section Editors:</dt><dd><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/contributors\" class=\"contributor contributor_credentials\">Scott Manaker, MD, PhD</a></dd><dd><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/contributors\" class=\"contributor contributor_credentials\">Charles J Lockwood, MD, MHCM</a></dd><dt><span> </span>Deputy Editors:</dt><dd><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/contributors\" class=\"contributor contributor_credentials\">Geraldine Finlay, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/contributors\" class=\"contributor contributor_credentials\">Vanessa A Barss, MD, FACOG</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Feb 26, 2018.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Amniotic fluid embolism syndrome (AFES) is a rare but catastrophic condition that occurs when amniotic fluid enters the maternal circulation [<a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/1-3\" class=\"abstract_t\">1-3</a>]. Prompt recognition is important so that therapies can be instituted quickly.</p><p>AFES is reviewed here. The management of critically ill obstetric patients is discussed separately. (See <a href=\"topic.htm?path=critical-illness-during-pregnancy-and-the-peripartum-period\" class=\"medical medical_review\">&quot;Critical illness during pregnancy and the peripartum period&quot;</a> and <a href=\"topic.htm?path=deep-vein-thrombosis-and-pulmonary-embolism-in-pregnancy-treatment\" class=\"medical medical_review\">&quot;Deep vein thrombosis and pulmonary embolism in pregnancy: Treatment&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">INCIDENCE</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>AFES is rare. Most studies indicate that the incidence is between 1 and 12 cases per 100,000 deliveries [<a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/4-13\" class=\"abstract_t\">4-13</a>]. However, these data may overestimate the true incidence since many studies made the diagnosis of AFES using nonspecific findings [<a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/14\" class=\"abstract_t\">14</a>]. Diagnostic criteria for the purposes of case definition in research have been proposed but have not been agreed upon [<a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/15,16\" class=\"abstract_t\">15,16</a>].</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h1\">PATHOPHYSIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Amniotic fluid is believed to enter the maternal circulation when the barrier between uterine vessels and amniotic fluid occurs and enters the systemic circulation. Hypotheses based upon animal data [<a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/2,17-23\" class=\"abstract_t\">2,17-23</a>] suggest that subsequent to amniotic fluid embolism, acute pulmonary hypertension and rapid right ventricular failure ensue (usually lasting 15 to 30 minutes) followed by left ventricular dysfunction; hypoxemic respiratory failure and cardiovascular collapse quickly ensue and culminate in systemic inflammation and noncardiogenic pulmonary edema. &#160;</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Although unclear, animal data suggest that left ventricular failure may be due to hypoxic injury to the left ventricle, release of maternal inflammatory mediators, or a direct depressant effect of amniotic fluid on the myocardium.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Factors that contribute to hypoxemic respiratory failure initially include severe <span class=\"nowrap\">ventilation/perfusion</span> mismatching from acute pulmonary hypertension and cardiogenic pulmonary edema and later in the course, noncardiogenic pulmonary edema [<a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/2,5\" class=\"abstract_t\">2,5</a>]. In those with noncardiogenic pulmonary edema, evidence for damage to the endothelial-alveolar membrane and a capillary leak syndrome includes the high protein concentration in edema fluid and the presence of amniotic fluid debris in the sputum and alveolar spaces, although the latter findings may be absent in some patients. (See <a href=\"topic.htm?path=noncardiogenic-pulmonary-edema\" class=\"medical medical_review\">&quot;Noncardiogenic pulmonary edema&quot;</a> and <a href=\"topic.htm?path=acute-respiratory-distress-syndrome-clinical-features-and-diagnosis-in-adults\" class=\"medical medical_review\">&quot;Acute respiratory distress syndrome: Clinical features and diagnosis in adults&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Reasons for neurologic symptoms are unclear but may be hypoxemia-related or due to direct embolization of amniotic debris to the brain. Although fetal squamous cells have also been described in the vascular bed of the maternal brain (as well as kidneys, liver, spleen, and pancreas), the significance of this is unclear since these findings can also be found in patients without AFES [<a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/24\" class=\"abstract_t\">24</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Several inflammatory markers have been described in AFES including decreased complement (C3, C4, and C1 esterase inhibitor) levels, elevated serum tryptase levels and pulmonary mast cell activity [<a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/25-28\" class=\"abstract_t\">25-28</a>]. In addition, an altered maternal immune response to fetal antigens, circulating leukotrienes and other arachidonic acid metabolites derived from the amniotic fluid, have been described [<a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/29-32\" class=\"abstract_t\">29-32</a>]. In severe cases the coagulation cascade is also activated.</p><p/><p class=\"headingAnchor\" id=\"H3276354861\"><span class=\"h1\">RISK FACTORS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>AFES may be more likely in situations when exchange of fluids between the maternal and fetal circulation occurs. However, the data to support these risk factors are flawed and none sufficient to alter standard obstetric care [<a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/4,8,9,33-35\" class=\"abstract_t\">4,8,9,33-35</a>]: </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Cesarean or instrumental vaginal delivery</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Precipitous or tumultuous labor</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Advanced maternal age (eg, &ge;35 years)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Placenta previa, placenta <span class=\"nowrap\">accrete/percreta/increta,</span> or placental abruption</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Grand multiparity (&ge;5 live births or stillbirths)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Cervical lacerations</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Fetal distress</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Eclampsia</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Pharmacologic induction of labor </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Uterine rupture</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Polyhydramnios</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Miscarriage, abortion, amniocentesis</p><p/><p>Duration or stage of labor does not appear to be a risk factor.</p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h1\">CLINICAL PRESENTATION</span></p><p class=\"headingAnchor\" id=\"H3009464466\"><span class=\"h2\">Onset of symptoms</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In the majority of cases (approximately 90 percent), AFES occurs during labor and delivery, or immediately postpartum. One national registry reported that 70 percent of cases occurred during labor, 11 percent after vaginal delivery, and 19 percent during cesarean delivery [<a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/5\" class=\"abstract_t\">5</a>]. Rarely, it has been reported as late as 48 hours after delivery, as well as following a first or second trimester abortion (medical or surgical), miscarriage, amniocentesis, or <span class=\"nowrap\">abdominal/uterine</span> trauma [<a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/5,35-41\" class=\"abstract_t\">5,35-41</a>]. </p><p class=\"headingAnchor\" id=\"H320468685\"><span class=\"h2\">Signs and symptoms</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In most patients (90 percent) the clinical presentation of AFES is typically abrupt, catastrophic, and rapidly progressive [<a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/7\" class=\"abstract_t\">7</a>]. Classically, patients present with cardiorespiratory compromise followed by hemorrhage from disseminated intravascular coagulopathy (DIC) and noncardiogenic pulmonary edema. Manifestations include: </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Aura &ndash; Up to one-third of patients may experience a sense of sudden doom, chills, nausea and vomiting, agitation, anxiety, or change in mental status that immediately precedes the event [<a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/5,7,42\" class=\"abstract_t\">5,7,42</a>]. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Cardiorespiratory failure <span class=\"nowrap\">and/or</span> arrest &ndash; Patients suddenly develop hypoxemic respiratory failure, hypotension from cardiogenic shock, <span class=\"nowrap\">and/or</span> cardiovascular <span class=\"nowrap\">collapse/cardiac</span> arrest. Typical clinical findings include oxygen desaturation, dyspnea, tachypnea, cyanosis, crackles, and occasionally, wheeze. Hypoventilation is unusual unless in the setting of respiratory arrest. Those with cardiac arrest can present with bradycardia, tachycardia, ventricular fibrillation, pulseless electrical activity (PEA) <span class=\"nowrap\">and/or</span> asystole. If patients survive the initial cardiorespiratory event, noncardiogenic pulmonary edema often develops (worsening dyspnea and tachypnea, crackles) as left ventricular failure resolves. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-cardiogenic-shock-in-acute-myocardial-infarction#H9\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of cardiogenic shock in acute myocardial infarction&quot;, section on 'Clinical presentation'</a> and <a href=\"topic.htm?path=advanced-cardiac-life-support-acls-in-adults\" class=\"medical medical_review\">&quot;Advanced cardiac life support (ACLS) in adults&quot;</a> and <a href=\"topic.htm?path=cardiopulmonary-arrest-in-pregnancy\" class=\"medical medical_review\">&quot;Cardiopulmonary arrest in pregnancy&quot;</a> and <a href=\"topic.htm?path=noncardiogenic-pulmonary-edema#H5\" class=\"medical medical_review\">&quot;Noncardiogenic pulmonary edema&quot;, section on 'Presentation and diagnosis'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hemorrhage &ndash; Hemorrhage from disseminated intravascular coagulation (DIC) typically occurs shortly after the development of cardiorespiratory compromise but may be the initial presentation [<a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/1,2,5,43\" class=\"abstract_t\">1,2,5,43</a>]. Prolonged bleeding from sites of invasive interventions and bruising are the most common manifestations of DIC. However, in some cases, major obstetric hemorrhage can occur. Case reports of AFES presenting as hemorrhage in the absence of antecedent cardiopulmonary compromise have been described [<a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/43,44\" class=\"abstract_t\">43,44</a>]. (See <a href=\"topic.htm?path=clinical-features-diagnosis-and-treatment-of-disseminated-intravascular-coagulation-in-adults#H2\" class=\"medical medical_review\">&quot;Clinical features, diagnosis, and treatment of disseminated intravascular coagulation in adults&quot;, section on 'Clinical manifestations'</a> and <a href=\"topic.htm?path=overview-of-the-etiology-and-evaluation-of-vaginal-bleeding-in-pregnant-women\" class=\"medical medical_review\">&quot;Overview of the etiology and evaluation of vaginal bleeding in pregnant women&quot;</a> and <a href=\"topic.htm?path=overview-of-postpartum-hemorrhage\" class=\"medical medical_review\">&quot;Overview of postpartum hemorrhage&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Neurologic manifestations &ndash; Tonic-clonic seizures (30 percent) and stroke (rare) are less common initial manifestations of AFES [<a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/5,45,46\" class=\"abstract_t\">5,45,46</a>]. </p><p/><p>There may be a less severe presentation of AFES (ie, partial amniotic fluid embolism syndrome) in which only some of the major symptoms and signs occur [<a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/17,47,48\" class=\"abstract_t\">17,47,48</a>]. Such patients generally present with the sudden onset of milder dyspnea and hypotension. The clinical course tends to be abbreviated and the prognosis is much better, compared to women who have the full syndrome.</p><p class=\"headingAnchor\" id=\"H2603523340\"><span class=\"h2\">Laboratory and imaging</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Laboratory findings are nonspecific and may include:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>An elevated white cell count (which is often nonspecifically elevated in pregnancy and during labor).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Anemia (which is often present in pregnancy). </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The laboratory features of DIC (elevated D-dimer, low fibrinogen [especially &lt;200 <span class=\"nowrap\">g/L],</span> thrombocytopenia). DIC occurs in up to 80 percent of patients with AFES [<a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/1,2,5\" class=\"abstract_t\">1,2,5</a>]. DIC can begin as quickly as 10 to 30 minutes after the onset of cardiopulmonary compromise or may be delayed by hours or days or occur in the absence of cardiorespiratory compromise [<a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/2,49-53\" class=\"abstract_t\">2,49-53</a>]. (See <a href=\"topic.htm?path=clinical-features-diagnosis-and-treatment-of-disseminated-intravascular-coagulation-in-adults\" class=\"medical medical_review\">&quot;Clinical features, diagnosis, and treatment of disseminated intravascular coagulation in adults&quot;</a>.)</p><p/><p>Arterial blood gas analysis typically reveals hypoxemia (which is often profound) and rarely hypercapnia. Metabolic acidosis can occur in those who suffer from prolonged cardiac arrest. (See <a href=\"topic.htm?path=arterial-blood-gases\" class=\"medical medical_review\">&quot;Arterial blood gases&quot;</a>.)</p><p>Radiographic findings (plain radiography and computed tomography) are nonspecific and range from normal imaging early in the course of the disease, to dense bilateral infiltrates consistent with pulmonary edema or hemorrhage. </p><p>Electrocardiography typically reveals sinus tachycardia but may also reveal arrhythmias typical of those seen in cardiac arrest. (See <a href=\"topic.htm?path=overview-of-sudden-cardiac-arrest-and-sudden-cardiac-death\" class=\"medical medical_review\">&quot;Overview of sudden cardiac arrest and sudden cardiac death&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H3708362525\"><span class=\"h2\">Fetal signs and symptoms</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In patients who have not yet delivered, fetal monitoring may show decelerations, loss of variability, and bradycardia due to fetal hypoxemia and uterine hypoperfusion. (See <a href=\"topic.htm?path=cardiopulmonary-arrest-in-pregnancy#H9057226\" class=\"medical medical_review\">&quot;Cardiopulmonary arrest in pregnancy&quot;, section on 'Fetal monitoring'</a>.)</p><p class=\"headingAnchor\" id=\"H12\"><span class=\"h1\">DIFFERENTIAL DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>There are numerous causes of hypotension, hypoxemia, <span class=\"nowrap\">and/or</span> hemorrhage in women who are pregnant or postpartum. In most patients with AFES, the distinguishing feature is the abrupt onset of cardiorespiratory symptoms during delivery or postpartum. The differential diagnosis can be narrowed by clinical assessment and imaging.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Hypotension and Shock</strong></p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Cardiogenic shock from peripartum cardiomyopathy or myocardial infarction may be distinguished from AFES by their slower onset and the presence of chest pain, and in some cases, a known diagnosis of cardiomyopathy or risk factors for ischemic heart disease. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-cardiogenic-shock-in-acute-myocardial-infarction\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of cardiogenic shock in acute myocardial infarction&quot;</a>.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Septic shock may be distinguished from AFES by fever, suspected infectious source, and elevated white cell count with left shift. (See <a href=\"topic.htm?path=sepsis-syndromes-in-adults-epidemiology-definitions-clinical-presentation-diagnosis-and-prognosis\" class=\"medical medical_review\">&quot;Sepsis syndromes in adults: Epidemiology, definitions, clinical presentation, diagnosis, and prognosis&quot;</a>.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Other causes of shock may be distinguished by the presence of a provoking factor such as the administration of medications (eg, anaphylactic shock). (See <a href=\"topic.htm?path=evaluation-of-and-initial-approach-to-the-adult-patient-with-undifferentiated-hypotension-and-shock\" class=\"medical medical_review\">&quot;Evaluation of and initial approach to the adult patient with undifferentiated hypotension and shock&quot;</a>.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Obstetric causes of shock (eg, placental abruption, uterine rupture) may be distinguished by examination findings and imaging and are more likely to present with vaginal bleeding (not related to disseminated intravascular coagulation [DIC]) or follow instrumentation. (See <a href=\"topic.htm?path=placental-abruption-clinical-features-and-diagnosis\" class=\"medical medical_review\">&quot;Placental abruption: Clinical features and diagnosis&quot;</a> and <a href=\"topic.htm?path=placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality\" class=\"medical medical_review\">&quot;Placenta previa: Epidemiology, clinical features, diagnosis, morbidity and mortality&quot;</a> and <a href=\"topic.htm?path=rupture-of-the-unscarred-uterus\" class=\"medical medical_review\">&quot;Rupture of the unscarred uterus&quot;</a>.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>High spinal anesthesia and local anesthetic toxicity may be suspected in those receiving anesthesia. (See <a href=\"topic.htm?path=local-anesthetic-systemic-toxicity\" class=\"medical medical_review\">&quot;Local anesthetic systemic toxicity&quot;</a> and <a href=\"topic.htm?path=anesthesia-for-cesarean-delivery\" class=\"medical medical_review\">&quot;Anesthesia for cesarean delivery&quot;</a> and <a href=\"topic.htm?path=adverse-effects-of-neuraxial-analgesia-and-anesthesia-for-obstetrics\" class=\"medical medical_review\">&quot;Adverse effects of neuraxial analgesia and anesthesia for obstetrics&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Embolism syndromes</strong></p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Acute pulmonary embolism (PE) is hard to distinguish clinically but can be readily identified by computed tomographic pulmonary angiography. Right ventricle enlargement on echocardiography may be seen in both AFES and PE. (See <a href=\"topic.htm?path=clinical-presentation-evaluation-and-diagnosis-of-the-nonpregnant-adult-with-suspected-acute-pulmonary-embolism\" class=\"medical medical_review\">&quot;Clinical presentation, evaluation, and diagnosis of the nonpregnant adult with suspected acute pulmonary embolism&quot;</a>.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Air embolism may present similarly but may be preceded by instrumentation (eg, cesarean delivery) and can be distinguished by visualization of air on imaging (although air rapidly dissipates on imaging). (See <a href=\"topic.htm?path=air-embolism\" class=\"medical medical_review\">&quot;Air embolism&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Acute respiratory failure</strong></p><p/><p class=\"bulletIndent2\">The differential diagnosis of acute respiratory failure in pregnancy is wide and discussed separately. (See <a href=\"topic.htm?path=acute-respiratory-failure-during-pregnancy-and-the-peripartum-period#H5\" class=\"medical medical_review\">&quot;Acute respiratory failure during pregnancy and the peripartum period&quot;, section on 'Etiologies'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Inflammatory syndromes</strong></p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Acute respiratory distress syndrome (ARDS) is typically slower in onset and preceded by precipitating factors (eg trauma, pneumonia). (See <a href=\"topic.htm?path=acute-respiratory-distress-syndrome-clinical-features-and-diagnosis-in-adults#H11\" class=\"medical medical_review\">&quot;Acute respiratory distress syndrome: Clinical features and diagnosis in adults&quot;, section on 'Diagnostic evaluation'</a>.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Aspiration pneumonia may occur during labor and delivery and is a classic complication of cesarean delivery (Mendelson's syndrome). The aspiration may be witnessed but is otherwise indistinguishable from AFES. (See <a href=\"topic.htm?path=aspiration-pneumonia-in-adults\" class=\"medical medical_review\">&quot;Aspiration pneumonia in adults&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Hemorrhage </strong></p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>DIC itself has a wide differential including sepsis, malignancy, trauma, transfusion reactions, and obstetric causes including preeclampsia, retained dead fetus, and acute fatty liver of pregnancy, many of which should be evident clinically or on imaging. (See <a href=\"topic.htm?path=clinical-features-diagnosis-and-treatment-of-disseminated-intravascular-coagulation-in-adults\" class=\"medical medical_review\">&quot;Clinical features, diagnosis, and treatment of disseminated intravascular coagulation in adults&quot;</a>.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Vaginal hemorrhage has a wide differential and is discussed separately. (See <a href=\"topic.htm?path=overview-of-the-etiology-and-evaluation-of-vaginal-bleeding-in-pregnant-women\" class=\"medical medical_review\">&quot;Overview of the etiology and evaluation of vaginal bleeding in pregnant women&quot;</a> and <a href=\"topic.htm?path=overview-of-postpartum-hemorrhage\" class=\"medical medical_review\">&quot;Overview of postpartum hemorrhage&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Neurologic syndromes</strong></p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Seizures may be eclampsia-, drug-, or medically-related (<a href=\"image.htm?imageKey=PC%2F61807\" class=\"graphic graphic_table graphicRef61807 \">table 1</a> and <a href=\"image.htm?imageKey=NEURO%2F106961\" class=\"graphic graphic_table graphicRef106961 \">table 2</a>), some of which may be identified clinically. (See <a href=\"topic.htm?path=evaluation-and-management-of-the-first-seizure-in-adults#H2\" class=\"medical medical_review\">&quot;Evaluation and management of the first seizure in adults&quot;, section on 'Causes of seizure'</a> and <a href=\"topic.htm?path=eclampsia\" class=\"medical medical_review\">&quot;Eclampsia&quot;</a>.)</p><p/><p/><p class=\"headingAnchor\" id=\"H13\"><span class=\"h1\">DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>AFES should be suspected in a pregnant or postpartum woman who develops abrupt onset hypotension, hypoxemia, cardiovascular compromise, hemorrhage in association with disseminated intravascular coagulation, <span class=\"nowrap\">and/or</span> acute neurologic changes. AFES is a clinical diagnosis of exclusion that is based upon the constellation of classic clinical findings and the exclusion of other causes of the presenting symptoms. (See <a href=\"#H12\" class=\"local\">'Differential diagnosis'</a> above.) </p><p>We do not recommend the routine insertion of a pulmonary artery catheter to draw a sample to identify amniotic fluid debris (squamous cells, trophoblastic cells, mucin, and lanugo) in the pulmonary circulation since such debris is common in the maternal circulation of women without AFES and is therefore, not diagnostic [<a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/54\" class=\"abstract_t\">54</a>]. </p><p>Similarly, lung biopsy is not routinely indicated. Although histologic diagnosis has been reported with detection of amniotic fluid components in the pulmonary circulation, it is not diagnostic since there appear to be women who die from the classic constellation of AFES symptoms who do not show any histologic evidence on autopsy [<a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/55,56\" class=\"abstract_t\">55,56</a>]. </p><p>Investigational diagnostic tests include:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Levels of zinc coproporphyrin-1 and sialyl Tn antigen have been shown to be increased in some patients with AFES that presented with cardiopulmonary collapse [<a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/57\" class=\"abstract_t\">57</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Measuring TKH-2 (a fetal antigen that can also be observed in maternal lung samples), insulin-like growth factor binding protein-1, or squamous cell carcinoma antigen have been detected in some patients with AFES but are of uncertain diagnostic significance [<a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/58-61\" class=\"abstract_t\">58-61</a>]. </p><p/><p>The diagnosis may be delayed due to a low threshold to suspect AFES, the rarity of the entity, atypical presentations, and the need to exclude other more common and serious disorders that present with the same symptoms. </p><p class=\"headingAnchor\" id=\"H14\"><span class=\"h1\">MANAGEMENT</span></p><p class=\"headingAnchor\" id=\"H2776196616\"><span class=\"h2\">Initial diagnostic and therapeutic approach</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A multidisciplinary, team-based approach (critical care, maternal-fetal medicine, respiratory care, nursing, and anesthesia specialists) is preferred because it allows <strong>simultaneous</strong> diagnostic evaluation and administration of therapy. </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Therapeutic &ndash; The treatment for AFES is supportive. Since most cases present with sudden cardiorespiratory <span class=\"nowrap\">failure/arrest</span> and hemorrhage, the airway and adequate intravenous access should be secured, and advanced cardiac life support protocols followed so that adequate tissue perfusion for both mother and fetus (if not yet delivered) can be ensured. Importantly, for patients who have not delivered, prompt delivery of the fetus is critical, provided that the fetus is viable. (See <a href=\"#H2587866501\" class=\"local\">'Management of shock and cardiac arrest'</a> below and <a href=\"#H17\" class=\"local\">'Management of respiratory failure'</a> below and <a href=\"#H21\" class=\"local\">'Management of hemorrhage and disseminated intravascular coagulopathy'</a> below and <a href=\"#H22\" class=\"local\">'Delivery of the fetus'</a> below.) </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Diagnostic &ndash; Bedside clinical evaluation and diagnostic investigations should be undertaken while initial resuscitative therapies are ongoing. This involves a thorough history and examination including <span class=\"nowrap\">vaginal/pelvic</span> examination, particularly in those who present with vaginal hemorrhage. Typical investigations include complete blood count, chemistries, renal and liver function tests, cardiac enzymes, brain natriuretic peptide levels, chest radiography, arterial blood gases, electrocardiography, <span class=\"nowrap\">and/or</span> bedside ultrasonography (if available). The primary purpose of initial investigations is to narrow the differential since AFES is a diagnosis of exclusion. Once stabilized, a more thorough investigation can be undertaken. (See <a href=\"#H12\" class=\"local\">'Differential diagnosis'</a> above and <a href=\"#H13\" class=\"local\">'Diagnosis'</a> above and <a href=\"topic.htm?path=indications-for-bedside-ultrasonography-in-the-critically-ill-adult-patient\" class=\"medical medical_review\">&quot;Indications for bedside ultrasonography in the critically-ill adult patient&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H2587866501\"><span class=\"h2\">Management of shock and cardiac arrest</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Initial strategies should focus on standard basic and advanced cardiac life support maneuvers to treat shock and cardiac arrest, the details of which are discussed separately. (See <a href=\"topic.htm?path=evaluation-of-and-initial-approach-to-the-adult-patient-with-undifferentiated-hypotension-and-shock\" class=\"medical medical_review\">&quot;Evaluation of and initial approach to the adult patient with undifferentiated hypotension and shock&quot;</a> and <a href=\"topic.htm?path=cardiopulmonary-arrest-in-pregnancy\" class=\"medical medical_review\">&quot;Cardiopulmonary arrest in pregnancy&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H111415461\"><span class=\"h3\">Hemodynamic support</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The approach to hypotensive patients with AFES is the same as among those without AFES with the exception that excessive fluid administration should be avoided since hypotension in AFES is almost always due to cardiogenic shock and coexisting intravascular hypovolemia is rare. However, in most cases, the diagnosis of AFES is not readily apparent and intravenous fluids are often given while an assessment of intravascular status is ongoing. Fluids should be administered as small boluses (250 to 500 mL) with frequent assessment of the response. Once the intravascular volume has been replenished or pulmonary edema becomes apparent, fluids should be discontinued. For patients who remain hypotensive after initial resuscitation and investigation, initiation of vasopressor therapy, typically norepinephrine, is appropriate [<a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/62\" class=\"abstract_t\">62</a>]. An inotrope may be added for those who have cardiogenic shock. Further details regarding vasopressor therapy in pregnant patients are discussed separately. (See <a href=\"topic.htm?path=critical-illness-during-pregnancy-and-the-peripartum-period#H14\" class=\"medical medical_review\">&quot;Critical illness during pregnancy and the peripartum period&quot;, section on 'Vasopressors'</a> and <a href=\"topic.htm?path=use-of-vasopressors-and-inotropes\" class=\"medical medical_review\">&quot;Use of vasopressors and inotropes&quot;</a> and <a href=\"topic.htm?path=prognosis-and-treatment-of-cardiogenic-shock-complicating-acute-myocardial-infarction#H17\" class=\"medical medical_review\">&quot;Prognosis and treatment of cardiogenic shock complicating acute myocardial infarction&quot;, section on 'Vasopressors and inotropes'</a>.)</p><p class=\"headingAnchor\" id=\"H17\"><span class=\"h2\">Management of respiratory failure</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The management of respiratory failure is supportive and includes the administration of supplemental oxygen, and in most cases mechanical ventilation. While noninvasive ventilation may be attempted for mild cases of respiratory failure, most patients have an illness severity that justifies intubation and mechanical ventilation. (See <a href=\"topic.htm?path=overview-of-mechanical-ventilation\" class=\"medical medical_review\">&quot;Overview of mechanical ventilation&quot;</a> and <a href=\"topic.htm?path=critical-illness-during-pregnancy-and-the-peripartum-period\" class=\"medical medical_review\">&quot;Critical illness during pregnancy and the peripartum period&quot;</a> and <a href=\"topic.htm?path=acute-respiratory-failure-during-pregnancy-and-the-peripartum-period\" class=\"medical medical_review\">&quot;Acute respiratory failure during pregnancy and the peripartum period&quot;</a>.)</p><p>Extracorporeal membrane oxygenation (ECMO) should not be routinely used and is generally avoided since the anticoagulation that is required for ECMO may increase the risk of bleeding in the setting of disseminated intravascular coagulopathy that is commonly found in this population. However, rare case reports suggest successful use in patients with refractory AFES such as those unresponsive to standard ventilator maneuvers or those undergoing prolonged cardiac arrest in whom oxygenation is required for fetal delivery [<a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/23,63\" class=\"abstract_t\">23,63</a>]. (See <a href=\"topic.htm?path=extracorporeal-membrane-oxygenation-ecmo-in-adults\" class=\"medical medical_review\">&quot;Extracorporeal membrane oxygenation (ECMO) in adults&quot;</a>.)</p><p>Case reports describe successful use of inhaled <a href=\"topic.htm?path=nitric-oxide-drug-information\" class=\"drug drug_general\">nitric oxide</a> and a right ventricular assist device in patients with refractory pulmonary hypertension and right ventricular failure from AFES [<a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/64,65\" class=\"abstract_t\">64,65</a>]. (See <a href=\"topic.htm?path=inhaled-nitric-oxide-in-adults-biology-and-indications-for-use\" class=\"medical medical_review\">&quot;Inhaled nitric oxide in adults: Biology and indications for use&quot;</a> and <a href=\"topic.htm?path=short-term-mechanical-circulatory-assist-devices\" class=\"medical medical_review\">&quot;Short-term mechanical circulatory assist devices&quot;</a>.)</p><p>Steroids should not be administered unless another indication for their use is present. (See <a href=\"topic.htm?path=glucocorticoid-therapy-in-septic-shock\" class=\"medical medical_review\">&quot;Glucocorticoid therapy in septic shock&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H21\"><span class=\"h2\">Management of hemorrhage and disseminated intravascular coagulopathy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Blood product transfusion may be required for some patients with bleeding due to disseminated intravascular coagulopathy (DIC). Importantly, in those with vaginal hemorrhage, a detailed examination and investigation should be undertaken to locate and treat the source of bleeding including excluding uterine atony (ie, the most common cause of postpartum hemorrhage). The management of DIC, complications of massive blood product transfusion, and vaginal bleeding are discussed separately. (See <a href=\"topic.htm?path=clinical-features-diagnosis-and-treatment-of-disseminated-intravascular-coagulation-in-adults\" class=\"medical medical_review\">&quot;Clinical features, diagnosis, and treatment of disseminated intravascular coagulation in adults&quot;</a> and <a href=\"topic.htm?path=massive-blood-transfusion\" class=\"medical medical_review\">&quot;Massive blood transfusion&quot;</a> and <a href=\"topic.htm?path=overview-of-the-etiology-and-evaluation-of-vaginal-bleeding-in-pregnant-women\" class=\"medical medical_review\">&quot;Overview of the etiology and evaluation of vaginal bleeding in pregnant women&quot;</a> and <a href=\"topic.htm?path=overview-of-postpartum-hemorrhage\" class=\"medical medical_review\">&quot;Overview of postpartum hemorrhage&quot;</a>.)</p><p><a href=\"topic.htm?path=factor-viia-activated-recombinant-human-drug-information\" class=\"drug drug_general\">Recombinant human factor VIIa</a> (rVIIa) has been used in patients with severe coagulopathy and bleeding, especially in those undergoing surgery to control postpartum hemorrhage [<a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/65,66\" class=\"abstract_t\">65,66</a>]. However, some experts believe that its use is associated with thrombotic morbidity and mortality (eg, stroke and pulmonary embolism) [<a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/67\" class=\"abstract_t\">67</a>]. We believe that factor VIIa use in patients with AFES should be reserved as a last resort and only for those with hemorrhage refractory to medical <span class=\"nowrap\">and/or</span> surgical intervention. (See <a href=\"topic.htm?path=recombinant-factor-viia-clinical-uses-dosing-and-adverse-effects\" class=\"medical medical_review\">&quot;Recombinant factor VIIa: Clinical uses, dosing, and adverse effects&quot;</a>.)</p><p>Successful use of C1 esterase inhibitor concentrate has also been reported but is not routine [<a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/68\" class=\"abstract_t\">68</a>].</p><p class=\"headingAnchor\" id=\"H22\"><span class=\"h2\">Delivery of the fetus</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>When AFES presents intrapartum, the need for immediate delivery must be determined. The decision is made on a case-by-case basis, but factors that favor urgent delivery include a nonreassuring fetal heart rate tracing, rapid and progressive deterioration of the mother's condition, or the opinion that delivery of the fetus may facilitate maternal resuscitative efforts. Operative vaginal delivery is reasonable if the cervix is fully dilated and the fetal head has descended to a station of at least <span class=\"nowrap\">+2/5</span>. Otherwise, an emergency cesarean delivery is indicated. (See <a href=\"topic.htm?path=operative-vaginal-delivery\" class=\"medical medical_review\">&quot;Operative vaginal delivery&quot;</a> and <a href=\"topic.htm?path=cardiopulmonary-arrest-in-pregnancy#H9057240\" class=\"medical medical_review\">&quot;Cardiopulmonary arrest in pregnancy&quot;, section on 'Delivery as part of the resuscitation process'</a>.) </p><p>Major maternal morbidity or death is a significant risk when a cesarean delivery is performed in the presence of coagulopathy. Some clinicians recommend that operative intervention not begin until the coagulopathy is corrected. However, this is not always possible, especially if a delay could lead to fetal death, further blood loss, and worsening of the coagulopathy. If a cesarean delivery has to be performed urgently, blood, fresh frozen plasma, platelets, and cryoprecipitate should be available in the operating room and should be administered if there is any evidence of impaired coagulation (eg, persistent bleeding without clotting from incision or needle sites). (See <a href=\"topic.htm?path=disseminated-intravascular-coagulation-during-pregnancy#H8\" class=\"medical medical_review\">&quot;Disseminated intravascular coagulation during pregnancy&quot;, section on 'Management of delivery'</a>.)</p><p class=\"headingAnchor\" id=\"H24\"><span class=\"h1\">PROGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>AFES is one of the leading causes of maternal mortality and is reported to cause 10 percent of all maternal deaths in developed countries [<a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/69\" class=\"abstract_t\">69</a>]. Maternal mortality rates are high and prognosis in those who survive is poor. </p><p>The maternal mortality rate has been reported to range from 10 to 90 percent [<a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/1,4,5,16,70-73\" class=\"abstract_t\">1,4,5,16,70-73</a>]. However accurate rates are hampered by the lack of consensus on the definition of AFES [<a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/16\" class=\"abstract_t\">16</a>]. While older reports generally suggest rates up to 90 percent, newer data report rates less than 50 percent, with an overall mortality of about 20 percent [<a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/4,8,9,16,73\" class=\"abstract_t\">4,8,9,16,73</a>]. </p><p>Hypoxemia, which is often profound, causes about 50 percent of the deaths that occur within the first hour [<a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/5,7\" class=\"abstract_t\">5,7</a>]. Approximately 85 percent of patients with AFES die from cardiogenic shock or cardiac arrest [<a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/7\" class=\"abstract_t\">7</a>].</p><p>Those who survive typically have a poor outcome, with as many as 85 percent suffering significant neurologic injury due to cerebral hypoxia [<a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/2,5\" class=\"abstract_t\">2,5</a>], although patients with milder presentations have better outcomes. (See <a href=\"topic.htm?path=hypoxic-ischemic-brain-injury-in-adults-evaluation-and-prognosis\" class=\"medical medical_review\">&quot;Hypoxic-ischemic brain injury in adults: Evaluation and prognosis&quot;</a>.)</p><p>Neonatal outcomes are also poor. The mortality rate is estimated to be between 20 and 60 percent and up to 50 percent who survive are neurologically intact [<a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/5,6\" class=\"abstract_t\">5,6</a>]. Overall neonatal outcomes have improved with prompt delivery [<a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/74\" class=\"abstract_t\">74</a>].</p><p>While case reports suggest successful pregnancy following AFES, the risk of recurrence is unknown since no case of recurrent AFES has been reported [<a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/75\" class=\"abstract_t\">75</a>]. </p><p class=\"headingAnchor\" id=\"H25\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Amniotic fluid embolism syndrome (AFES) is a catastrophic condition that typically occurs during labor and delivery or postpartum. It is unpredictable, unpreventable, and rare (1 to 12 cases per 100,000 deliveries) and its pathophysiology is poorly understood. (See <a href=\"#H2\" class=\"local\">'Incidence'</a> above and <a href=\"#H4\" class=\"local\">'Pathophysiology'</a> above and <a href=\"#H3276354861\" class=\"local\">'Risk factors'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>AFES is characterized by the abrupt and fulminant onset of hypotension due to cardiogenic <span class=\"nowrap\">shock/arrest,</span> hypoxemic respiratory failure, and hemorrhage from disseminated intravascular coagulation. (See <a href=\"#H8\" class=\"local\">'Clinical presentation'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>AFES is a clinical diagnosis that is based upon the constellation of classic clinical findings and the exclusion of other causes of the presenting symptoms. (See <a href=\"#H13\" class=\"local\">'Diagnosis'</a> above and <a href=\"#H12\" class=\"local\">'Differential diagnosis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A multidisciplinary, team-based approach (critical care, maternofetal, respiratory care, nursing, and anesthesia specialists) is preferred because it allows <strong>simultaneous</strong> diagnostic evaluation and administration of therapy. </p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>The treatment for AFES is supportive. The airway and adequate intravenous access should be secured and advanced cardiac life support protocols followed so that adequate tissue perfusion for both mother and fetus (if not yet delivered) can be ensured. Importantly, for patients who have not delivered, prompt delivery of the fetus is critical, provided that the fetus is viable. (See <a href=\"#H2587866501\" class=\"local\">'Management of shock and cardiac arrest'</a> above and <a href=\"#H17\" class=\"local\">'Management of respiratory failure'</a> above and <a href=\"#H21\" class=\"local\">'Management of hemorrhage and disseminated intravascular coagulopathy'</a> above and <a href=\"#H22\" class=\"local\">'Delivery of the fetus'</a> above.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Bedside clinical evaluation and diagnostic investigations involve a thorough history and examination as well as a gynecological examination. Typical investigations include complete blood count, chemistries, renal and liver function tests, cardiac enzymes, brain natriuretic peptide levels, chest radiography, arterial blood gases, electrocardiography, <span class=\"nowrap\">and/or</span> bedside ultrasonography (if available). Once stabilized, a more thorough investigation can be undertaken. (See <a href=\"#H2776196616\" class=\"local\">'Initial diagnostic and therapeutic approach'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Maternal mortality due to AFES remains high, although less than in previous years. However, even those who survive generally have a poor outcome, most often neurologic injury due to cerebral hypoxia. Neonatal outcomes are also poor, although they improve with early delivery. (See <a href=\"#H24\" class=\"local\">'Prognosis'</a> above.)</p><p/></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/1\" class=\"nounderline abstract_t\">Gilmore DA, Wakim J, Secrest J, Rawson R. Anaphylactoid syndrome of pregnancy: a review of the literature with latest management and outcome data. AANA J 2003; 71:120.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/2\" class=\"nounderline abstract_t\">Gist RS, Stafford IP, Leibowitz AB, Beilin Y. Amniotic fluid embolism. Anesth Analg 2009; 108:1599.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/3\" class=\"nounderline abstract_t\">Clark SL. Amniotic fluid embolism. Obstet Gynecol 2014; 123:337.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/4\" class=\"nounderline abstract_t\">Abenhaim HA, Azoulay L, Kramer MS, Leduc L. Incidence and risk factors of amniotic fluid embolisms: a population-based study on 3 million births in the United States. Am J Obstet Gynecol 2008; 199:49.e1.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/5\" class=\"nounderline abstract_t\">Clark SL, Hankins GD, Dudley DA, et al. Amniotic fluid embolism: analysis of the national registry. Am J Obstet Gynecol 1995; 172:1158.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/6\" class=\"nounderline abstract_t\">Tuffnell DJ. United kingdom amniotic fluid embolism register. BJOG 2005; 112:1625.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/7\" class=\"nounderline abstract_t\">Morgan M. Amniotic fluid embolism. Anaesthesia 1979; 34:20.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/8\" class=\"nounderline abstract_t\">Kramer MS, Rouleau J, Baskett TF, et al. Amniotic-fluid embolism and medical induction of labour: a retrospective, population-based cohort study. Lancet 2006; 368:1444.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/9\" class=\"nounderline abstract_t\">Knight M, Tuffnell D, Brocklehurst P, et al. Incidence and risk factors for amniotic-fluid embolism. Obstet Gynecol 2010; 115:910.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/10\" class=\"nounderline abstract_t\">Shen F, Wang L, Yang W, Chen Y. From appearance to essence: 10&nbsp;years review of atypical amniotic fluid embolism. Arch Gynecol Obstet 2016; 293:329.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/11\" class=\"nounderline abstract_t\">Yoneyama K, Sekiguchi A, Matsushima T, et al. Clinical characteristics of amniotic fluid embolism: an experience of 29 years. J Obstet Gynaecol Res 2014; 40:1862.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/12\" class=\"nounderline abstract_t\">Fitzpatrick KE, Tuffnell D, Kurinczuk JJ, Knight M. Incidence, risk factors, management and outcomes of amniotic-fluid embolism: a population-based cohort and nested case-control study. BJOG 2016; 123:100.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/13\" class=\"nounderline abstract_t\">Roberts CL, Algert CS, Knight M, Morris JM. Amniotic fluid embolism in an Australian population-based cohort. BJOG 2010; 117:1417.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/14\" class=\"nounderline abstract_t\">Bonnet MP, Zlotnik D, Saucedo M, et al. Maternal Death Due to Amniotic Fluid Embolism: A National Study in France. Anesth Analg 2018; 126:175.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/15\" class=\"nounderline abstract_t\">Clark SL, Romero R, Dildy GA, et al. Proposed diagnostic criteria for the case definition of amniotic fluid embolism in research studies. Am J Obstet Gynecol 2016; 215:408.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/16\" class=\"nounderline abstract_t\">Kobayashi H, Akasaka J, Naruse K, et al. Comparison of the Different Definition Criteria for the Diagnosis of Amniotic Fluid Embolism. J Clin Diagn Res 2017; 11:QC18.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/17\" class=\"nounderline abstract_t\">Clark SL. New concepts of amniotic fluid embolism: a review. Obstet Gynecol Surv 1990; 45:360.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/18\" class=\"nounderline abstract_t\">ATTWOOD HD, DOWNING ES. EXPERIMENTAL AMNIOTIC FLUID AND MECONIUM EMBOLISM. Surg Gynecol Obstet 1965; 120:255.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/19\" class=\"nounderline abstract_t\">Reis RL, Pierce WS, Behrendt DM. Hemodynamic effects of amniotic fluid embolism. Surg Gynecol Obstet 1969; 129:45.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/20\" class=\"nounderline abstract_t\">Clark SL, Cotton DB, Gonik B, et al. Central hemodynamic alterations in amniotic fluid embolism. Am J Obstet Gynecol 1988; 158:1124.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/21\" class=\"nounderline abstract_t\">Clark SL, Montz FJ, Phelan JP. Hemodynamic alterations associated with amniotic fluid embolism: a reappraisal. Am J Obstet Gynecol 1985; 151:617.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/22\" class=\"nounderline abstract_t\">Shechtman M, Ziser A, Markovits R, Rozenberg B. Amniotic fluid embolism: early findings of transesophageal echocardiography. Anesth Analg 1999; 89:1456.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/23\" class=\"nounderline abstract_t\">Stanten RD, Iverson LI, Daugharty TM, et al. Amniotic fluid embolism causing catastrophic pulmonary vasoconstriction: diagnosis by transesophageal echocardiogram and treatment by cardiopulmonary bypass. Obstet Gynecol 2003; 102:496.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/24\" class=\"nounderline abstract_t\">Liban E, Raz S. A clinicopathologic study of fourteen cases of amniotic fluid embolism. Am J Clin Pathol 1969; 51:477.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/25\" class=\"nounderline abstract_t\">Nishio H, Matsui K, Miyazaki T, et al. A fatal case of amniotic fluid embolism with elevation of serum mast cell tryptase. Forensic Sci Int 2002; 126:53.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/26\" class=\"nounderline abstract_t\">Farrar SC, Gherman RB. Serum tryptase analysis in a woman with amniotic fluid embolism. A case report. J Reprod Med 2001; 46:926.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/27\" class=\"nounderline abstract_t\">Fineschi V, Gambassi R, Gherardi M, Turillazzi E. The diagnosis of amniotic fluid embolism: an immunohistochemical study for the quantification of pulmonary mast cell tryptase. Int J Legal Med 1998; 111:238.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/28\" class=\"nounderline abstract_t\">Benson MD. A hypothesis regarding complement activation and amniotic fluid embolism. Med Hypotheses 2007; 68:1019.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/29\" class=\"nounderline abstract_t\">Benson MD, Kobayashi H, Silver RK, et al. Immunologic studies in presumed amniotic fluid embolism. Obstet Gynecol 2001; 97:510.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/30\" class=\"nounderline abstract_t\">Benson MD. Current concepts of immunology and diagnosis in amniotic fluid embolism. Clin Dev Immunol 2012; 2012:946576.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/31\" class=\"nounderline abstract_t\">Azegami M, Mori N. Amniotic fluid embolism and leukotrienes. Am J Obstet Gynecol 1986; 155:1119.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/32\" class=\"nounderline abstract_t\">Benson MD. Nonfatal amniotic fluid embolism. Three possible cases and a new clinical definition. Arch Fam Med 1993; 2:989.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/33\" class=\"nounderline abstract_t\">Turner LA, Kramer MS, Liu S, Maternal Mortality and Morbidity Study Group of the Canadian Perinatal Surveillance System. Cause-specific mortality during and after pregnancy and the definition of maternal death. Chronic Dis Can 2002; 23:31.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/34\" class=\"nounderline abstract_t\">Kramer MS, Rouleau J, Liu S, et al. Amniotic fluid embolism: incidence, risk factors, and impact on perinatal outcome. BJOG 2012; 119:874.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/35\" class=\"nounderline abstract_t\">Drukker L, Sela HY, Ioscovich A, et al. Amniotic Fluid Embolism: A Rare Complication of Second-Trimester Amniocentesis. Fetal Diagn Ther 2017; 42:77.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/36\" class=\"nounderline abstract_t\">Lawson HW, Atrash HK, Franks AL. Fatal pulmonary embolism during legal induced abortion in the United States from 1972 to 1985. Am J Obstet Gynecol 1990; 162:986.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/37\" class=\"nounderline abstract_t\">Hasaart TH, Essed GG. Amniotic fluid embolism after transabdominal amniocentesis. Eur J Obstet Gynecol Reprod Biol 1983; 16:25.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/38\" class=\"nounderline abstract_t\">Mainprize TC, Maltby JR. Amniotic fluid embolism: a report of four probable cases. Can Anaesth Soc J 1986; 33:382.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/39\" class=\"nounderline abstract_t\">Ellingsen CL, Eggeb&oslash; TM, Lexow K. Amniotic fluid embolism after blunt abdominal trauma. Resuscitation 2007; 75:180.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/40\" class=\"nounderline abstract_t\">Rainio J, Penttil&auml; A. Amniotic fluid embolism as cause of death in a car accident--a case report. Forensic Sci Int 2003; 137:231.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/41\" class=\"nounderline abstract_t\">Kaaniche FM, Chaari A, Zekri M, et al. Amniotic fluid embolism complicating medical termination of pregnancy. Can J Anaesth 2016; 63:871.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/42\" class=\"nounderline abstract_t\">Mu Y, McDonnell N, Li Z, et al. Amniotic fluid embolism as a cause of maternal mortality in China between 1996 and 2013: a population-based retrospective study. BMC Pregnancy Childbirth 2016; 16:316.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/43\" class=\"nounderline abstract_t\">Liao CY, Luo FJ. Amniotic Fluid Embolism with Isolated Coagulopathy: A Report of Two Cases. J Clin Diagn Res 2016; 10:QD03.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/44\" class=\"nounderline abstract_t\">Davies S. Amniotic fluid embolism and isolated disseminated intravascular coagulation. Can J Anaesth 1999; 46:456.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/45\" class=\"nounderline abstract_t\">Price TM, Baker VV, Cefalo RC. Amniotic fluid embolism. Three case reports with a review of the literature. Obstet Gynecol Surv 1985; 40:462.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/46\" class=\"nounderline abstract_t\">Woo YS, Hong SC, Park SM, Cho KH. Ischemic stroke related to an amniotic fluid embolism during labor. J Clin Neurosci 2015; 22:767.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/47\" class=\"nounderline abstract_t\">Masson RG, Ruggieri J, Siddiqui MM. Amniotic fluid embolism: definitive diagnosis in a survivor. Am Rev Respir Dis 1979; 120:187.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/48\" class=\"nounderline abstract_t\">Wasser WG, Tessler S, Kamath CP, Sackin AJ. Nonfatal amniotic fluid embolism: a case report of post-partum respiratory distress with histopathologic studies. Mt Sinai J Med 1979; 46:388.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/49\" class=\"nounderline abstract_t\">Peterson EP, Taylor HB. Amniotic fluid embolism. An analysis of 40 cases. Obstet Gynecol 1970; 35:787.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/50\" class=\"nounderline abstract_t\">Beller FK. Disseminated intravascular coagulation and consumption coagulopathy in obstetrics. Obstet Gynecol Annu 1974; 3:267.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/51\" class=\"nounderline abstract_t\">Bastien JL, Graves JR, Bailey S. Atypical presentation of amniotic fluid embolism. Anesth Analg 1998; 87:124.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/52\" class=\"nounderline abstract_t\">Malhotra P, Agarwal R, Awasthi A, et al. Delayed presentation of amniotic fluid embolism: lessons from a case diagnosed at autopsy. Respirology 2007; 12:148.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/53\" class=\"nounderline abstract_t\">Tanaka H, Katsuragi S, Osato K, et al. Value of fibrinogen in cases of maternal death related to amniotic fluid embolism. J Matern Fetal Neonatal Med 2017; 30:2940.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/54\" class=\"nounderline abstract_t\">Lee W, Ginsburg KA, Cotton DB, Kaufman RH. Squamous and trophoblastic cells in the maternal pulmonary circulation identified by invasive hemodynamic monitoring during the peripartum period. Am J Obstet Gynecol 1986; 155:999.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/55\" class=\"nounderline abstract_t\">Sinicina I, Pankratz H, Bise K, Matevossian E. Forensic aspects of post-mortem histological detection of amniotic fluid embolism. Int J Legal Med 2010; 124:55.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/56\" class=\"nounderline abstract_t\">Tamura N, Farhana M, Oda T, et al. Amniotic fluid embolism: Pathophysiology from the perspective of pathology. J Obstet Gynaecol Res 2017; 43:627.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/57\" class=\"nounderline abstract_t\">Kanayama N, Tamura N. Amniotic fluid embolism: pathophysiology and new strategies for management. J Obstet Gynaecol Res 2014; 40:1507.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/58\" class=\"nounderline abstract_t\">Oi H, Kobayashi H, Hirashima Y, et al. Serological and immunohistochemical diagnosis of amniotic fluid embolism. Semin Thromb Hemost 1998; 24:479.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/59\" class=\"nounderline abstract_t\">Kobayashi H, Ooi H, Hayakawa H, et al. Histological diagnosis of amniotic fluid embolism by monoclonal antibody TKH-2 that recognizes NeuAc alpha 2-6GalNAc epitope. Hum Pathol 1997; 28:428.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/60\" class=\"nounderline abstract_t\">Legrand M, Rossignol M, Dreux S, et al. Diagnostic accuracy of insulin-like growth factor binding protein-1 for amniotic fluid embolism*. Crit Care Med 2012; 40:2059.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/61\" class=\"nounderline abstract_t\">Koike N, Oi H, Naruse K, et al. Squamous cell carcinoma antigen as a novel candidate marker for amniotic fluid embolism. J Obstet Gynaecol Res 2017; 43:1815.</a></li><li class=\"breakAll\">Cheng SH, Baldisseri MR. Management of amniotic fluid embolism. In: Evidence-Based Critical Care, Hyzy RC (Ed), Springer, Switzerland 2017. p.737-741.</li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/63\" class=\"nounderline abstract_t\">Hsieh YY, Chang CC, Li PC, et al. Successful application of extracorporeal membrane oxygenation and intra-aortic balloon counterpulsation as lifesaving therapy for a patient with amniotic fluid embolism. Am J Obstet Gynecol 2000; 183:496.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/64\" class=\"nounderline abstract_t\">McDonnell NJ, Chan BO, Frengley RW. Rapid reversal of critical haemodynamic compromise with nitric oxide in a parturient with amniotic fluid embolism. Int J Obstet Anesth 2007; 16:269.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/65\" class=\"nounderline abstract_t\">Nagarsheth NP, Pinney S, Bassily-Marcus A, et al. Successful placement of a right ventricular assist device for treatment of a presumed amniotic fluid embolism. Anesth Analg 2008; 107:962.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/66\" class=\"nounderline abstract_t\">Leighton BL, Wall MH, Lockhart EM, et al. Use of recombinant factor VIIa in patients with amniotic fluid embolism: a systematic review of case reports. Anesthesiology 2011; 115:1201.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/67\" class=\"nounderline abstract_t\">Lockwood CJ, Bach R, Guha A, et al. Amniotic fluid contains tissue factor, a potent initiator of coagulation. Am J Obstet Gynecol 1991; 165:1335.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/68\" class=\"nounderline abstract_t\">Todo Y, Tamura N, Itoh H, et al. Therapeutic application of C1 esterase inhibitor concentrate for clinical amniotic fluid embolism: a case report. Clin Case Rep 2015; 3:673.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/69\" class=\"nounderline abstract_t\">Berg CJ, Callaghan WM, Syverson C, Henderson Z. Pregnancy-related mortality in the United States, 1998 to 2005. Obstet Gynecol 2010; 116:1302.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/70\" class=\"nounderline abstract_t\">Gilbert WM, Danielsen B. Amniotic fluid embolism: decreased mortality in a population-based study. Obstet Gynecol 1999; 93:973.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/71\" class=\"nounderline abstract_t\">Clark SL. Amniotic fluid embolism. Clin Perinatol 1986; 13:801.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/72\" class=\"nounderline abstract_t\">Suidan JS. Amniotic fluid embolism. Middle East J Anaesthesiol 1989; 10:279.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/73\" class=\"nounderline abstract_t\">Benson MD. Amniotic fluid embolism mortality rate. J Obstet Gynaecol Res 2017; 43:1714.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/74\" class=\"nounderline abstract_t\">Clark SL. Amniotic fluid embolism. Clin Obstet Gynecol 2010; 53:322.</a></li><li><a href=\"https://www.uptodate.com/contents/amniotic-fluid-embolism-syndrome/abstract/75\" class=\"nounderline abstract_t\">Caeiro AFC, Ramilo IDTM, Santos AP, et al. Amniotic Fluid Embolism. Is a New Pregnancy Possible? Case Report. Rev Bras Ginecol Obstet 2017; 39:369.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 1591 Version 13.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H25\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">INCIDENCE</a></li><li><a href=\"#H4\" id=\"outline-link-H4\">PATHOPHYSIOLOGY</a></li><li><a href=\"#H3276354861\" id=\"outline-link-H3276354861\">RISK FACTORS</a></li><li><a href=\"#H8\" id=\"outline-link-H8\">CLINICAL PRESENTATION</a><ul><li><a href=\"#H3009464466\" id=\"outline-link-H3009464466\">Onset of symptoms</a></li><li><a href=\"#H320468685\" id=\"outline-link-H320468685\">Signs and symptoms</a></li><li><a href=\"#H2603523340\" id=\"outline-link-H2603523340\">Laboratory and imaging</a></li><li><a href=\"#H3708362525\" id=\"outline-link-H3708362525\">Fetal signs and symptoms</a></li></ul></li><li><a href=\"#H12\" id=\"outline-link-H12\">DIFFERENTIAL DIAGNOSIS</a></li><li><a href=\"#H13\" id=\"outline-link-H13\">DIAGNOSIS</a></li><li><a href=\"#H14\" id=\"outline-link-H14\">MANAGEMENT</a><ul><li><a href=\"#H2776196616\" id=\"outline-link-H2776196616\">Initial diagnostic and therapeutic approach</a></li><li><a href=\"#H2587866501\" id=\"outline-link-H2587866501\">Management of shock and cardiac arrest</a><ul><li><a href=\"#H111415461\" id=\"outline-link-H111415461\">- Hemodynamic support</a></li></ul></li><li><a href=\"#H17\" id=\"outline-link-H17\">Management of respiratory failure</a></li><li><a href=\"#H21\" id=\"outline-link-H21\">Management of hemorrhage and disseminated intravascular coagulopathy</a></li><li><a href=\"#H22\" id=\"outline-link-H22\">Delivery of the fetus</a></li></ul></li><li><a href=\"#H24\" id=\"outline-link-H24\">PROGNOSIS</a></li><li><a href=\"#H25\" id=\"outline-link-H25\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"PULM/1591|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=PC/61807\" class=\"graphic graphic_table\">- Causes of acute symptomatic seizures</a></li><li><a href=\"image.htm?imageKey=NEURO/106961\" class=\"graphic graphic_table\">- Medications associated with seizures</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=acute-respiratory-distress-syndrome-clinical-features-and-diagnosis-in-adults\" class=\"medical medical_review\">Acute respiratory distress syndrome: Clinical features and diagnosis in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=acute-respiratory-failure-during-pregnancy-and-the-peripartum-period\" class=\"medical medical_review\">Acute respiratory failure during pregnancy and the peripartum period</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=advanced-cardiac-life-support-acls-in-adults\" class=\"medical medical_review\">Advanced cardiac life support (ACLS) in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=adverse-effects-of-neuraxial-analgesia-and-anesthesia-for-obstetrics\" class=\"medical medical_review\">Adverse effects of neuraxial analgesia and anesthesia for obstetrics</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=air-embolism\" class=\"medical medical_review\">Air embolism</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=anesthesia-for-cesarean-delivery\" class=\"medical medical_review\">Anesthesia for cesarean delivery</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=arterial-blood-gases\" class=\"medical medical_review\">Arterial blood gases</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=aspiration-pneumonia-in-adults\" class=\"medical medical_review\">Aspiration pneumonia in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cardiopulmonary-arrest-in-pregnancy\" class=\"medical medical_review\">Cardiopulmonary arrest in pregnancy</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-features-diagnosis-and-treatment-of-disseminated-intravascular-coagulation-in-adults\" class=\"medical medical_review\">Clinical features, diagnosis, and treatment of disseminated intravascular coagulation in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-cardiogenic-shock-in-acute-myocardial-infarction\" class=\"medical medical_review\">Clinical manifestations and diagnosis of cardiogenic shock in acute myocardial infarction</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-presentation-evaluation-and-diagnosis-of-the-nonpregnant-adult-with-suspected-acute-pulmonary-embolism\" class=\"medical medical_review\">Clinical presentation, evaluation, and diagnosis of the nonpregnant adult with suspected acute pulmonary embolism</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=critical-illness-during-pregnancy-and-the-peripartum-period\" class=\"medical medical_review\">Critical illness during pregnancy and the peripartum period</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=deep-vein-thrombosis-and-pulmonary-embolism-in-pregnancy-treatment\" class=\"medical medical_review\">Deep vein thrombosis and pulmonary embolism in pregnancy: Treatment</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=disseminated-intravascular-coagulation-during-pregnancy\" class=\"medical medical_review\">Disseminated intravascular coagulation during pregnancy</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=eclampsia\" class=\"medical medical_review\">Eclampsia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=evaluation-and-management-of-the-first-seizure-in-adults\" class=\"medical medical_review\">Evaluation and management of the first seizure in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=evaluation-of-and-initial-approach-to-the-adult-patient-with-undifferentiated-hypotension-and-shock\" class=\"medical medical_review\">Evaluation of and initial approach to the adult patient with undifferentiated hypotension and shock</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=extracorporeal-membrane-oxygenation-ecmo-in-adults\" class=\"medical medical_review\">Extracorporeal membrane oxygenation (ECMO) in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=glucocorticoid-therapy-in-septic-shock\" class=\"medical medical_review\">Glucocorticoid therapy in septic shock</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=hypoxic-ischemic-brain-injury-in-adults-evaluation-and-prognosis\" class=\"medical medical_review\">Hypoxic-ischemic brain injury in adults: Evaluation and prognosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=indications-for-bedside-ultrasonography-in-the-critically-ill-adult-patient\" class=\"medical medical_review\">Indications for bedside ultrasonography in the critically-ill adult patient</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=inhaled-nitric-oxide-in-adults-biology-and-indications-for-use\" class=\"medical medical_review\">Inhaled nitric oxide in adults: Biology and indications for use</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=local-anesthetic-systemic-toxicity\" class=\"medical medical_review\">Local anesthetic systemic toxicity</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=massive-blood-transfusion\" class=\"medical medical_review\">Massive blood transfusion</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=noncardiogenic-pulmonary-edema\" class=\"medical medical_review\">Noncardiogenic pulmonary edema</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=operative-vaginal-delivery\" class=\"medical medical_review\">Operative vaginal delivery</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-mechanical-ventilation\" class=\"medical medical_review\">Overview of mechanical ventilation</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-postpartum-hemorrhage\" class=\"medical medical_review\">Overview of postpartum hemorrhage</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-sudden-cardiac-arrest-and-sudden-cardiac-death\" class=\"medical medical_review\">Overview of sudden cardiac arrest and sudden cardiac death</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-the-etiology-and-evaluation-of-vaginal-bleeding-in-pregnant-women\" class=\"medical medical_review\">Overview of the etiology and evaluation of vaginal bleeding in pregnant women</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=placenta-previa-epidemiology-clinical-features-diagnosis-morbidity-and-mortality\" class=\"medical medical_review\">Placenta previa: Epidemiology, clinical features, diagnosis, morbidity and mortality</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=placental-abruption-clinical-features-and-diagnosis\" class=\"medical medical_review\">Placental abruption: Clinical features and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=prognosis-and-treatment-of-cardiogenic-shock-complicating-acute-myocardial-infarction\" class=\"medical medical_review\">Prognosis and treatment of cardiogenic shock complicating acute myocardial infarction</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=recombinant-factor-viia-clinical-uses-dosing-and-adverse-effects\" class=\"medical medical_review\">Recombinant factor VIIa: Clinical uses, dosing, and adverse effects</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=rupture-of-the-unscarred-uterus\" class=\"medical medical_review\">Rupture of the unscarred uterus</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=sepsis-syndromes-in-adults-epidemiology-definitions-clinical-presentation-diagnosis-and-prognosis\" class=\"medical medical_review\">Sepsis syndromes in adults: Epidemiology, definitions, clinical presentation, diagnosis, and prognosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=short-term-mechanical-circulatory-assist-devices\" class=\"medical medical_review\">Short-term mechanical circulatory assist devices</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=use-of-vasopressors-and-inotropes\" class=\"medical medical_review\">Use of vasopressors and inotropes</a></li></ul></div></div>","javascript":null}